Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024

Archive ouverte

Ploin, Dominique | Alexandre, Mathilde | Ventelou, Bruno | Che, Didier | Coignard, Bruno | Boulanger, Nathalie | Burucoa, Christophe | Caron, François | Gallian, Pierre | Hansmann, Yves | Lienhardt, Christian | Minodier, Philippe | Partouche, Henri | Revest, Mathieu | Saidani, Nadia | Salvat, Gilles | Vignier, Nicolas | Floreani, Sylvie | Henry, Sabine | Pozzetto, Bruno | Hoen, Bruno

Edité par CCSD ; European Centre for Disease Prevention and Control -

International audience. Within the International Health Regulations framework, the French High Council for Public Health was mandated in 2022 by health authorities to establish a list of priority infectious diseases for public health, surveillance and research in mainland and overseas France. Aim Our objective was to establish this list. Methods A multi-criteria decision analysis was used, as recommended by the European Centre for Disease Prevention and Control. A list of 95 entities (infectious diseases or groups of these, including the World Health Organization (WHO)-labelled ‘Disease X’) was established by 17 infectious disease experts. Ten criteria were defined to score entities: incidence rate, case fatality rate, potential for emergence and spread, impact on the individual, on society, on socially vulnerable groups, on the healthcare system, and need for new preventive tools, new curative therapies, and surveillance. Each criterion was assigned a relative weight by 77 multidisciplinary experts. For each entity, 98 physicians from various specialties rated each criterion against the entity, using a four-class Likert-type scale; the ratings were converted into numeric values with a nonlinear scale and respectively weighted to calculate the entity score. Results Fifteen entities were ranked as high-priorities, including Disease X and 14 known pathologies (e.g. haemorrhagic fevers, various respiratory viral infections, arboviral infections, multidrug-resistant bacterial infections, invasive meningococcal and pneumococcal diseases, prion diseases, rabies, and tuberculosis). Conclusion The priority entities agreed with those of the WHO in 2023; almost all were currently covered by the French surveillance and alert system. Repeating this analysis periodically would keep the list updated.

Suggestions

Du même auteur

Avis relatif à la conduite à tenir pour les cas confirmés d’infection àMonkeypox virus (MPXV) à risque de forme grave et pour lespersonnes contacts à risque d’infection par MPXV. Avis relatif à la conduite à tenir pour les cas confirmés d’infection àMonkeypox virus (MPXV) à risque de forme grave et pour lespersonnes contacts à risque d’infection par MPXV: AVIS du HCSP

Archive ouverte | Pozzetto, Bruno | CCSD

Avis. En complément de son avis du 24 mai 2022, le Haut Conseil de la santé publique recommande, s’agissant des personnes à risque de formes graves d’infection à Monkeypox virus (MPXV) cas confirmés ou contact à ris...

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Archive ouverte | Charlier, Caroline | CCSD

International audience

Covid-19 : dépistage en milieu scolaire. Covid-19 : dépistage en milieu scolaire: Revue de la Littérature : Analyse littérature sur « susceptibilité des enfants au Covid-19, fréquence des formes graves et rôle des enfants dans la transmission »

Archive ouverte | Glélé, Ludwig Serge Aho | CCSD

International audience. Le Sénat a sollicité l’expertise du HCSP sur la stratégie de dépistage du Covid-19 en milieu scolaire.Le HCSP recommande de ne pas mettre en place des campagnes de dépistages systématiques tr...

Chargement des enrichissements...